Fifty-two meshes of e-flow rapid® were characterized for tobramycin delivery with a laser diffractometer after 6 months of home use by cystic fibrosis patients treated with various nebulized drugs. Three meshes were out of order and 30 considered to be defective for tobramycin delivery. The use of the specific mesh cleaning shower system permitted 14 defective meshes to be in the expected range of nebulized volume.
Keywords: Cystic fibrosis; In vitro study; Mesh-nebulizer; Tobramycin.
Copyright © 2019 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.